Although no studies have so far reported on survivin and tumor metastasis in orthotopic ovarian cancer animal models, several studies have shown that silencing BIRC5 expression with siRNA, shRNA, or YM155 inhibited cell proliferation and sensitized the cell response to chemotherapy [22, 37–40]. Here, BIRC5 is linked to ovarian cancer.